The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides specialty pharmacy services and mail services; this segment operates nearly 10,000 retail stores under the Walgreens and Duane Reade brands in the United States; and six specialty pharmacies.

The Retail Pharmacy International segment sells prescription drugs and health and wellness, beauty, personal care and other consumer products through its pharmacy-led health and beauty stores and optical practices, as well as online and an integrated mobile application. This segment operated 4,428 retail stores under the Boots, Benavides and Ahumada in the United Kingdom, Thailand, Norway, the Netherlands, Mexico and elsewhere, and 550 optical practices, including 165 on a franchise basis.

The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home health care supplies and equipment, as well as provides related services to pharmacies and other health care providers.

Investors receive a 4.00% dividend. The Walgreens Boots Alliance stock price target at Baird is $68. The consensus target is just $53.55, and shares ended Wednesday at $47.88.

All five companies pay very dependable dividends and their stocks have reasonable upside to the Wall Street targets. With even moderate appreciation in the share prices, investors should be looking at double-digit total return potential. In a market that is very long in the tooth, that makes a ton of sense now.

Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use